| Wendy Metia Gardner, LICSW | |
|
600 Sun Temple Dr, Madison, AL 35758-8643 | |
| (256) 288-3333 | |
| (256) 288-3334 |
| Full Name | Wendy Metia Gardner |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 17 Years |
| Location | 600 Sun Temple Dr, Madison, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598363145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4531C (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Impact Behavioral Counseling Llc | 1355604836 | 16 |
News Archive
Coronary syndromes vary in severity, ranging from unstable angina, non-ST segment elevation myocardial infarction, to ST-segment elevation myocardial infarction, the most severe diagnosis. Little data exist about changing trends in acute myocardial infarction and whether death rates are increasing or decreasing.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
The research, a collaborative project between Queen's University Belfast and Ulster University, began at the Queen's Centre for Cancer Research and Cell Biology in 2014, and was led by Professor Mohamed El-Tanani.
After a 10-year clinical trial of a jaw joint replacement developed by Peter Quinn of the University of Pennsylvania School of Dental Medicine, the Food and Drug Administration has given it a thumbs-up.
› Verified 6 days ago
| Entity Name | Impact Behavioral Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386169050 PECOS PAC ID: 1355604836 Enrollment ID: O20180622002111 |
News Archive
Coronary syndromes vary in severity, ranging from unstable angina, non-ST segment elevation myocardial infarction, to ST-segment elevation myocardial infarction, the most severe diagnosis. Little data exist about changing trends in acute myocardial infarction and whether death rates are increasing or decreasing.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
The research, a collaborative project between Queen's University Belfast and Ulster University, began at the Queen's Centre for Cancer Research and Cell Biology in 2014, and was led by Professor Mohamed El-Tanani.
After a 10-year clinical trial of a jaw joint replacement developed by Peter Quinn of the University of Pennsylvania School of Dental Medicine, the Food and Drug Administration has given it a thumbs-up.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Metia Gardner, LICSW 600 Sun Temple Dr, Madison, AL 35758-8643 Ph: (256) 288-3333 | Wendy Metia Gardner, LICSW 600 Sun Temple Dr, Madison, AL 35758-8643 Ph: (256) 288-3333 |
News Archive
Coronary syndromes vary in severity, ranging from unstable angina, non-ST segment elevation myocardial infarction, to ST-segment elevation myocardial infarction, the most severe diagnosis. Little data exist about changing trends in acute myocardial infarction and whether death rates are increasing or decreasing.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
The research, a collaborative project between Queen's University Belfast and Ulster University, began at the Queen's Centre for Cancer Research and Cell Biology in 2014, and was led by Professor Mohamed El-Tanani.
After a 10-year clinical trial of a jaw joint replacement developed by Peter Quinn of the University of Pennsylvania School of Dental Medicine, the Food and Drug Administration has given it a thumbs-up.
› Verified 6 days ago
Laurel Custer, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1634 Slaughter Rd Ste C, Madison, AL 35758 Phone: 256-822-2375 Fax: 256-584-2330 | |
Debbie Kay Duquette, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 120 W Dublin Dr Ste 202, Madison, AL 35758 Phone: 256-929-5507 Fax: 888-440-7284 | |
April S Motton, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 600 Sun Temple Dr, Madison, AL 35758 Phone: 256-975-4291 Fax: 256-429-9411 | |
Linda Mcgee Thompson, LCSW-PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 450 Lanier Rd, Madison, AL 35758 Phone: 256-774-4500 Fax: 256-774-4573 | |
Amber Stricklin, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 Sun Temple Dr, Madison, AL 35758 Phone: -- | |
Mr. James Franklin Waller, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8075 Madison Blvd, Suite 101, Madison, AL 35758 Phone: 256-772-6220 Fax: 256-460-0030 | |
Doris A Bell, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8215 Madison Blvd, Ste 150, Madison, AL 35758 Phone: 256-325-2500 Fax: 866-896-3657 |